| Bid Price | 0.80p | High Price | 1.20p |
|---|
| Ask Price | 1.00p | Low Price | 0.76p |
|---|
| Open Price | 1.00p | Spread | 19.64% |
|---|
| Prev Close | 1.05p | Volume | 2,173,149 |
|---|
Synairgen PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Mar 28, 2025 | 1.00 | 1.20 | 0.76 | 0.90 | 2,173,149 |
| Mar 27, 2025 | 0.86 | 1.14 | 0.81 | 1.05 | 1,360,878 |
| Mar 26, 2025 | 1.00 | 1.14 | 0.81 | 1.00 | 1,110,689 |
| Mar 25, 2025 | 0.80 | 1.02 | 0.80 | 1.00 | 281,813 |
| Mar 24, 2025 | 0.90 | 1.09 | 0.80 | 1.05 | 2,279,510 |
Synairgen PLC Information
| Name | Synairgen PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00B0381Z20 | Epic | SNG |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | AMSM |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 75,000 | Trading Status | Closed |
|---|
| Shares in Issue | 1.10 bn | Prev Close | 1.05p |
|---|
| PE Ratio | | Market Cap | £9.92 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 9.761596 | Quick Ratio | 8.231911 |
|---|
Synairgen PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 19/08/21 | SEXR | Richard Marsden | CEO | 296,959 @ £1.40 | £415,743.00 |
| 19/08/21 | EXR | Richard Marsden | CEO | 538,063 @ £0.01 | £5,381.00 |
| 19/08/21 | SEXR | Phillip Monk | RES | 220,878 @ £1.40 | £309,229.00 |
| 19/08/21 | EXR | Phillip Monk | RES | 400,212 @ £0.01 | £4,002.00 |
| 19/08/21 | SEXR | John Ward | RES | 269,963 @ £1.40 | £377,948.00 |
| 19/08/21 | EXR | John Ward | RES | 489,148 @ £0.01 | £4,891.00 |
| 19/10/20 | EXR | Richard Marsden | CEO | 386,842 @ £1.75 | £676,974.00 |
| 19/10/20 | EXR | John Ward | RES | 147,330 @ £1.75 | £257,828.00 |
| 26/03/20 | PLAC | Simon Shaw | RES | 57,143 @ £0.35 | £20,000.00 |
| 26/03/20 | PLAC | David Campbell | NED | 28,571 @ £0.35 | £10,000.00 |
Synairgen PLC News
